These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25035934)

  • 1. Operational modelling to guide implementation and scale-up of diagnostic tests within the health system: exploring opportunities for parasitic disease diagnostics based on example application for tuberculosis.
    Langley I; Adams E; Doulla B; Squire SB
    Parasitology; 2014 Dec; 141(14):1795-802. PubMed ID: 25035934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools.
    Lin HH; Langley I; Mwenda R; Doulla B; Egwaga S; Millington KA; Mann GH; Murray M; Squire SB; Cohen T
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):996-1004. PubMed ID: 21740663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preface on advances in diagnostics for infectious and parasitic diseases: detecting parasites of medical and veterinary importance.
    Stothard JR; Adams E
    Parasitology; 2014 Dec; 141(14):1781-8. PubMed ID: 25415359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of novel tuberculosis diagnostics--will countries be able to afford it?
    Pantoja A; Kik SV; Denkinger CM
    J Infect Dis; 2015 Apr; 211 Suppl 2():S67-77. PubMed ID: 25765108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of parasitic diseases: current scenario and future needs.
    Momčilović S; Cantacessi C; Arsić-Arsenijević V; Otranto D; Tasić-Otašević S
    Clin Microbiol Infect; 2019 Mar; 25(3):290-309. PubMed ID: 29730224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
    Dowdy DW; O'Brien MA; Bishai D
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health costs for tuberculosis suspects in Wake County, North Carolina, United States.
    Park PH; Holland DP; Wade A; Goswami ND; Bissette D; Stout JE
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):759-63. PubMed ID: 23676158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TB diagnostic tests: how do we figure out their costs?
    Sohn H; Minion J; Albert H; Dheda K; Pai M
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):723-33. PubMed ID: 19681700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach.
    Langley I; Lin HH; Egwaga S; Doulla B; Ku CC; Murray M; Cohen T; Squire SB
    Lancet Glob Health; 2014 Oct; 2(10):e581-91. PubMed ID: 25304634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools.
    Mann G; Squire SB; Bissell K; Eliseev P; Du Toit E; Hesseling A; Nicol M; Detjen A; Kritski A
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1518-24. PubMed ID: 21144235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of infections and resistance in veterinary and human parasites.
    Hunt PW
    Vet Parasitol; 2011 Aug; 180(1-2):12-46. PubMed ID: 21700392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic challenges associated with tuberculosis diagnostic development.
    Hanrahan CF; Shah M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):499-510. PubMed ID: 24766367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluations of point of care testing strategies for active tuberculosis.
    Zwerling A; Dowdy D
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):313-25. PubMed ID: 23763529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New diagnostic tools for tuberculosis.
    Perkins MD
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S182-8. PubMed ID: 11144551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New tuberculosis technologies: challenges for retooling and scale-up.
    Pai M; Palamountain KM
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1281-90. PubMed ID: 23107630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis in clinical parasitology: when and why?
    Wong SS; Fung KS; Chau S; Poon RW; Wong SC; Yuen KY
    Exp Biol Med (Maywood); 2014 Nov; 239(11):1443-60. PubMed ID: 24668556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operational models and criteria for incorporating microbial whole genome sequencing in hospital microbiology - A systematic literature review.
    Mintzer V; Moran-Gilad J; Simon-Tuval T
    Clin Microbiol Infect; 2019 Sep; 25(9):1086-1095. PubMed ID: 31039443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.